NeuroDerm News and Activities

NeuroDerm is owned by Mitsubishi Tanabe Pharma.

Mitsubishi Tanabe Pharma is a company listed under the stock ticker 4508 (JP).

Mitsubishi Tanabe Pharma has a direct presence in 6 countries.

Mitsubishi Tanabe Pharma has 5 subsidiaries including Mitsubishi Tanabe Pharma America, Mitsubishi Tanabe Pharma Canada and Mitsubishi Tanabe Pharma Europe.

Acquisition, funding and merger involving Mitsubishi Tanabe Pharma.

• Tanabe Pharma Corporation will change its company name to Tanabe Pharma Corporation on Dec 1, 2025. (posted on November 12 2025).
• Bain Capital has acquired Mitsubishi Tanabe Pharma (posted on February 12 2025).

View the org chart displaying its 17 main executives

Most searched biographies at NeuroDerm

• Kengo Isshiki, Chief Executive Officer
• Junya Namba, Director
• Kenji Taguchi, Director

Popular executive movements at NeuroDerm

• Liron Green, who was Human Resources and Talent Acquisition Manager, is promoted to Senior Manager, Human Resources and Talent Acquisition  (posted on November 12 2025).

Popular executive movements at Mitsubishi Tanabe Pharma

• Masahiko Ohtsuki has joined the company as Chief Research and Development Officer  (posted on May 12 2026).
• Hajime Minami has joined the company as Executive Officer, Head of Sales  (posted on May 12 2026).
• Shintaro Kohmoto who was Director, becomes Chief Transformation Officer and General Counsel  (posted on May 12 2026).

Click here to view some more movements at Mitsubishi Tanabe Pharma

Create your alert
to follow the executive moves at NeuroDerm.

Mitsubishi Tanabe Pharma has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by NeuroDerm

• Mitsubishi Tanabe Pharma Corporation Provides U.S. Regulatory Update on ND0612
• Positive Results from Phase 3 BouNDless Trial Evaluating ND0612 in Parkinson’s Disease Patients with Motor Fluctuations
• World Parkinson’s Day (WPD) - April 11th 2023
• News and Events
• Positive Results from the Pivotal Phase III BouNDless Trial Evaluating ND0612 in Parkinson’s Disease Patients with Motor Fluctuations
• Press Releases – Page 2 – NeuroDerm
• Press Releases – NeuroDerm
• Press Releases – NeuroDerm
• Press Releases – NeuroDerm
• Press Releases – NeuroDerm
• View more press releases Close

Social media about NeuroDerm

• NeuroDerm on Wikipedia, Google News & Yahoo Finance
• NeuroDerm on LinkedIn, X (Twitter) & YouTube